Evaluation of real-world cost savings and utilization of biosimilar drugs in a community-based oncology practice.
Journal of Clinical Oncology, Volume 39, Issue 28_suppl, Page 73-73, October 2021.
Go to Source
This article was first shared by INDoximity
This article was first shared by INDoximity: https://indoximity.com